New Study Identifies Distinct Entity in Pachychoroid Disease: Pachyvitelliform Maculopathy
Written By : Dr. Kamal Kant Kohli
Published On 2023-07-23 14:30 GMT | Update On 2023-07-23 14:30 GMT
Advertisement
Israel: Researchers led by Assaf Hilely have identified a novel entity within the pachychoroid disease spectrum known as pachyvitelliform maculopathy (PVM). Pachychoroid disease is characterized by the thickening of the choroid layer in the eye, and PVM is associated with acquired vitelliform lesions (AVL) and retinal pigment epithelium (RPE) dysfunction.
The study published in The British Journal of Ophthalmology was a retrospective, multicenter, observational analysis, involving the review of medical records and multimodal imaging of patients with pachychoroid disease and AVL. Seventeen eyes of 17 patients were included in the PVM group, with a mean age of 71.41 years. The average follow-up period was 33.15 months.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.